Deregulation of BRCA1/2-directed miRNA and alteration of BRCA1/2 may share a common mechanism that affects the prognosis of ovarian cancer patients treated with platinum-based chemotherapy. The gene discussed is BRCA1; the disease is ovarian carcinoma.